Stay updated on Risankizumab Maintenance in Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Risankizumab Maintenance in Psoriasis Clinical Trial page.

Latest updates to the Risankizumab Maintenance in Psoriasis Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check18 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1. This appears to be a versioning update to the documentation with no changes to the study details.SummaryDifference0.0%

- Check32 days agoChange DetectedAdded: Show glossary; Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0; Removed: Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4. These changes affect only UI text and metadata and do not alter substantive study information, eligibility criteria, or results.SummaryDifference0.1%

- Check39 days agoChange DetectedRevision: v3.3.4 added. Revision: v3.3.3 removed.SummaryDifference0.0%

- Check68 days agoChange DetectedLocations section was reorganized into a single comprehensive list of participating sites across the US and various countries, consolidating numerous state and country entries. The previous per-location headings (e.g., Alabama Locations) were removed, and the HHS Vulnerability Disclosure link was deleted.SummaryDifference3%

- Check89 days agoChange DetectedAdded Revision: v3.3.2 and removed Revision: v3.3.1, indicating a minor version update with no user-facing changes observed. The change does not affect core content, navigation, or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Risankizumab Maintenance in Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab Maintenance in Psoriasis Clinical Trial page.